- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01065350
A Comparison of Ketofol (Ketamine and Propofol Admixture) Versus Propofol as Induction Agents on Hemodynamic Parameters
A Comparison of Ketofol (Ketamine and Propofol Admixture) vs. Propofol as Induction Agents on Hemodynamic Parameters
Study Overview
Detailed Description
This is a pilot study to compare the hemodynamic changes that occur during induction with a novel drug combination known as ketofol with that of propofol. Propofol and ketamine are widely used as induction agents and their effects on patient hemodynamics are well known. Many of these drug-induced changes are undesirable and when used alone sometimes lead to hemodynamic effects on opposite ends of the spectrum, ie. hypotension (propofol) and hypertension (ketamine). We will investigate the hemodynamic changes associated with this drug combination referred to as "ketofol" (ketamine/propofol admixture) during induction compared with propofol as the gold standard induction agent used widely in anesthetic practice. If we validate that the changes produced by the ketofol admixture are favorable, we will then test its use in a wider setting of patient populations including emergency department intubations and the trauma setting.
Background: Propofol is a non-opioid, non-barbiturate, sedative-hypnotic agent with rapid onset and short duration of action. It possesses many favorable effects such as an antiemetic effect and reliably produces sedation and amnesia (Felfernig Jour of Royal Naval Medical Service, '06; White International Anesth Clinics, '88; Willman Ann of Emer Med, '07). However, there are several undesirable side effects such as cardiovascular and respiratory depression. In addition, Propofol as a sole agent has no analgesic properties. These drug-induced side effects have led to alternative drugs being used with the hopes of a more favorable side effect profile. Ketamine is an example of one such drug. Ketamine is a phencyclidine derivative commonly classified as a dissociative sedative with fairly rapid onset and short duration of action (Felfernig Jour of Royal Naval Medical Service, '06; White International Anesth Clinics, '88; Willman Ann of Emer Med, '07). It causes little or no respiratory and cardiovascular depression and unlike propofol, has pain relieving properties. Ketamine as a single induction agent, however, is limited by emergence phenomena including postoperative dreaming and hallucinations, however these are attenuated by the administration of benzodiazepines. Also ketamine in induction doses 1-4.5 mg/kg can have some undesirable effects on hemodynamics (opposite of propofol) in certain patient populations including ischemic heart disease (IHD), and patients with increases in intracranial hypertension and intracranial pressure (ICP). Effectiveness of the two agents in combination has been recently demonstrated and this new combination could allow a novel induction agent with favorable effects on hemodynamics (Felfernig Jour of Royal Naval Medical Service, '06; Hui Jour of Amer Soc of Anesth, '95; Willman Ann of Emer Med, '07). To date, this combination known as ketofol has been used most extensively for procedural sedation in the Emergency Department but has not yet been standardized as an induction agent. We are obtaining funding for a pilot study to validate the use of ketofol as an induction agent.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Hampshire
-
Lebanon, New Hampshire, United States, 03756
- Dartmouth Hitchcock Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- American Society of Anesthesiologists (ASA) physical status I and II who are to undergo elective general, urologic, orthopedic, plastic, or gynecologic surgery.
Exclusion Criteria:
- patients with age less than 18 yr or over 60 yr,
- emergency surgery,
- patients undergoing neurosurgical procedures,
- any procedure with adjunctive analgesia,
- any patient on chronic opiate use,
- females who are known to be pregnant,
- patients who had ingested psychotropic or sedative medication within one month of investigation,
- patients with personality disorders,
- weight greater than 20% of ideal, and
- any known contraindications to ketamine or propofol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Propofol
As part of the induction, patients will be given 2 milligrams of propofol per kilogram (mg/kg) of body weight.
The clinician will receive a 20 milliliter (mL) syringe of propofol.
If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
|
As part of the induction, subjects will be given 2 milligrams per kilogram of body weight (mg/kg) of propofol.
The clinician will receive a 20 milliliter (mL) syringe of propofol.
If the dose, 2 mg/kg, does not add up to a total of 20 mL, normal saline will be added to make up for the 20 mL.
The clinician and observer will be blinded to the medication and doses being administered during induction given that both syringes, syringes in the propofol and ketofol groups, will look identical (will both appear to be propofol only).
The propofol group will also be given an additional 10 mL syringe of propofol due to any patient responding to stimulus after induction.
The 10 mL syringe represents 1 mg/kg of propofol.
If patient receives both the 20 and 10ml syringe, he or she will receive a total of 3mg/kg of propofol.
Other Names:
|
Experimental: Ketofol
As part of the induction, patients will be given 20 mL syringe of an admixture called "ketofol," which combines ketamine and propofol in one syringe.
The dose is weight-based such that ketamine will represent 0.75 mg/kg of the dose and propofol, 1.5 mg/kg of the dose.
|
As part of the induction, patients will be given 20ml syringe of ketofol which is weight based such that ketamine will represent 0.75mg/kg of the dose and propofol, 1.5mg/kg.
The clinician and observer will be blinded to the medication and doses being administered during induction given that both 20ml syringes (propofol group and ketofol group) will look identical (will both appear to be propofol only).
Additional 10ml syringe will be given due to any patient responding to stimulus after induction.
The 10ml syringe will represent 0.25mg/kg of ketamine and 0.5mg/kg of propofol.
If the patient receives both the 20 and 10ml rescue syringe, he or she will receive a total of 1mg/kg of ketamine and 2mg/kg of propofol.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent of Subjects With a Greater Than 20% Decrease in Systolic Blood Pressure (SBP) Following Induction of General Anesthesia
Time Frame: Baseline, 5 minutes, 10 minutes, 30 minutes post induction
|
Blood pressure was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel.
The percentage of subjects experiencing decreases in SBP of greater than 20% during the specified time intervals is reported, as compared to the baseline systolic blood pressure reading.
There are two numbers in a blood pressure reading, and they are expressed in millimeters of mercury (mm Hg).
This tells how high in millimeters the pressure of your blood raises a column of mercury.
The numbers usually are expressed in the form of a fraction; an example of a blood pressure reading is 120/80 mm Hg.
The first, or top, number (120 in the example) is the systolic pressure.
The systolic pressure is the measure of your blood pressure as the heart contracts and pumps blood.
|
Baseline, 5 minutes, 10 minutes, 30 minutes post induction
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percent of Subjects With a Greater Than 20% Decrease in Diastolic Blood Pressure (DBP) Following Induction of General Anesthesia
Time Frame: Baseline, 5 minutes, 10 minutes, 30 minutes post induction
|
Blood pressure was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel.
The percentage of subjects experiencing decreases in DBP of greater than 20% during the specified time intervals is reported, as compared to the baseline DBP reading.
The second or lower number of a blood pressure reading is the DBP and is the measure taken when your heart is at rest.
|
Baseline, 5 minutes, 10 minutes, 30 minutes post induction
|
Percent of Subjects With a Greater Than 20% Decrease in Mean Arterial Pressure (MAP) Following Induction of General Anesthesia
Time Frame: Baseline, 5 minutes, 10 minutes, 30 minutes post induction
|
MAP was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel.
The percentage of subjects experiencing decreases in MAP of greater than 20% during the specified time intervals is reported, as compared to the baseline MAP reading.
|
Baseline, 5 minutes, 10 minutes, 30 minutes post induction
|
Average Change in Cardiac Output (CO)
Time Frame: Baseline, 5 minutes, 10 minutes post induction
|
CO was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel. The average change in CO as compared to baseline CO during the specified time intervals is reported. CO is defined as the quantity of blood ejected per minute by the heart into the systemic circulation. It is the product of the heart rate (HR) (beats per minute) times the stroke volume (SV) (milliliters of blood ejected during each contraction). |
Baseline, 5 minutes, 10 minutes post induction
|
Average Change in Cardiac Index (CI)
Time Frame: Baseline, 5 minutes, 10 minutes post induction
|
CI was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel. The average change in CI as compared to the baseline CI during the specified time intervals is reported. To determine CI, cardiac output is divided by the body surface area in order to account for body size. |
Baseline, 5 minutes, 10 minutes post induction
|
Average Change in Heart Rate (HR)
Time Frame: Baseline, 5 minutes, 10 minutes post induction
|
HR was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel.
The average change in HR (as compared to baseline HR) during the specified time intervals is reported.
|
Baseline, 5 minutes, 10 minutes post induction
|
Average Change in Systolic Blood Pressure (SBP)
Time Frame: Baseline, 5 minutes, 10 minutes post induction
|
Blood pressure was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel.
The average change in SBP (as compared to baseline SBP) during the specified time intervals is reported.
|
Baseline, 5 minutes, 10 minutes post induction
|
Average Change in Diastolic Blood Pressure (DBP)
Time Frame: Baseline, 5 minutes, 10 minutes post induction
|
Blood pressure was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel.
The average change in DBP (as compared to baseline DBP) during the specified time intervals is reported.
|
Baseline, 5 minutes, 10 minutes post induction
|
Average Change in Mean Arterial Pressure (MAP)
Time Frame: Baseline, 5 minutes, 10 minutes post induction
|
MAP was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel. The average change in MAP from baseline during the specified time intervals is reported. MAP is a term used in medicine to describe an average blood pressure in an individual. It is defined as the average arterial pressure during a single cardiac cycle. |
Baseline, 5 minutes, 10 minutes post induction
|
Average Change in Total Peripheral Resistance (TPR)
Time Frame: Baseline, 5 minutes, 10 minutes post induction
|
TPR was recorded every minute for a total of 30 minutes after anesthesia was induced and readings were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel.
The average change in TPR from baseline during the specified time intervals is reported.
TPR is the overall resistance to blood flow through the systemic blood vessels.
|
Baseline, 5 minutes, 10 minutes post induction
|
Average Change in Total Peripheral Resistance Index (TPRI)
Time Frame: Baseline, 5 minutes, 10 minutes post induction
|
TPRI was recorded every minute for a total of 30 minutes after anesthesia was induced and results were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel.
The average change in TPRI from baseline during the specified time intervals is reported.
|
Baseline, 5 minutes, 10 minutes post induction
|
Average Change in Stroke Volume (SV)
Time Frame: Baseline, 5 minutes, 10 minutes post induction
|
SV was recorded every minute for a total of 30 minutes after anesthesia was induced and results were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel.
The average change in SV from baseline during the specified time intervals is reported.
SV is the milliliters of blood ejected during each contraction of the heart.
|
Baseline, 5 minutes, 10 minutes post induction
|
Average Change in Stroke Volume Index (SVI)
Time Frame: Baseline, 5 minutes, 10 minutes post induction
|
SVI was recorded every minute for a total of 30 minutes after anesthesia was induced and results were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel.
The average change in SVI (as compared to baseline SVI) during the specified time intervals is reported.
To determine SVI, stroke volume is divided by the body surface area in order to account for body size.
|
Baseline, 5 minutes, 10 minutes post induction
|
Average Change in Stroke Volume Variation (SVV)
Time Frame: Baseline, 5 minutes, 10 minutes post induction
|
SVV was recorded every minute for a total of 30 minutes after anesthesia was induced and results were captured via a Non-Invasive Cardiac Output Monitor [NICOM], Cheetah Medical, Israel.
SVV is a dynamic flow-based parameter and together with cardiac output provides an indication of fluid responsiveness.
The average change in SVV (as compared to baseline SVV) during the specified time intervals is reported.
SVV is calculated by taking the SVmax - SVmin /*100/ SV mean.
|
Baseline, 5 minutes, 10 minutes post induction
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nathan J Smischney, MD, Mayo Clinic
- Study Director: Matthew Koff, MD, Dartmouth-Hitchcock Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Dissociative
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Excitatory Amino Acid Antagonists
- Excitatory Amino Acid Agents
- Hypnotics and Sedatives
- Ketamine
- Propofol
Other Study ID Numbers
- 22063
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Pressure
-
SE HealthCentre for Aging and Brain Health InnovationCompletedHypertension | Blood Pressure | Hypotension | High Blood Pressure | Low Blood PressureCanada
-
DongGuk UniversityActive, not recruitingHypertension | Blood Pressure | Ambulatory Blood Pressure | Home Blood Pressure MeasurementKorea, Republic of
-
University of JordanCompletedBlood Pressure | Heart Rate | Airway PressureJordan
-
ROX Medical, Inc.CompletedHypertension | Blood Pressure, High | Blood Pressure, Resistant | Blood Pressure, UncontrolledUnited Kingdom, Netherlands, Belgium
-
Istituto Auxologico ItalianoRecruitingArterial Hypertension | Ambulatory Blood Pressure Monitoring | Blood Pressure Determination | Home Blood Pressure MonitoringItaly
-
RadiRad Co., Ltd.Hualien Tzu Chi General HospitalNot yet recruitingBlood Pressure
-
Riphah International UniversityRecruiting
-
GE HealthcareNot yet recruiting
-
Guangdong Provincial People's HospitalRecruiting
-
Guangdong Provincial People's HospitalRecruiting
Clinical Trials on Propofol
-
Hopital FochCompleted
-
Konkuk University Medical CenterCompletedCoronary Artery Disease | Valvular Heart DiseaseKorea, Republic of
-
University Medical Center GroningenCompletedAnesthesia | Hemodynamic Instability | Interaction | Disorder of Oxygen TransportNetherlands
-
Asan Medical CenterCompletedPopulation Pharmacokinetics/Pharmacodynamics (PK/PD) of Microemulsion Propofol in Healthy VolunteersHealthyKorea, Republic of
-
Tiva GroupMedtronic - MITGCompleted
-
Pontificia Universidad Catolica de ChileCompletedSurgery | Anesthesia | Depth of Anesthesia | NeonateChile
-
Mansoura UniversityCompleted
-
KVG Medical College and HospitalUnknown
-
Acibadem UniversityCompleted